| P50 | author | Anke Salmen | Q89091810 |
| | Maximilian Pistor | Q99726008 |
| P2093 | author name string | Andrew Chan | |
| | Robert Hoepner | |
| | Maud Bagnoud | |
| | Jana Remlinger | |
| | Ivo Meli | |
| | Myriam Briner | |
| | Sara Schuetz | |
| P2860 | cites work | JNK Signaling: Regulation and Functions Based on Complex Protein-Protein Partnerships | Q26741279 |
| | Stage-Specific Role of Interferon-Gamma in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis | Q26781529 |
| | The specific JNK inhibitor SP600125 targets tumour necrosis factor-alpha production and epithelial cell apoptosis in acute murine colitis | Q83185411 |
| | Transcription factor Smad-independent T helper 17 cell induction by transforming-growth factor-β is mediated by suppression of eomesodermin | Q84159819 |
| | Activation of astrocytes and expression of inflammatory cytokines in rats with experimental autoimmune encephalomyelitis | Q90465455 |
| | Vitamin D increases glucocorticoid efficacy via inhibition of mTORC1 in experimental models of multiple sclerosis | Q91571313 |
| | Transmembrane tumour necrosis factor is neuroprotective and regulates experimental autoimmune encephalomyelitis via neuronal nuclear factor-kappaB. | Q48906070 |
| | c-Jun N-terminal kinases (JNKs) mediate pro-inflammatory actions of microglia | Q48987486 |
| | Role of mitogen-activated protein kinases in inducible nitric oxide synthase and TNFalpha expression in human fetal astrocytes. | Q53670078 |
| | Divergent roles for p55 and p75 tumor necrosis factor receptors in the pathogenesis of MOG(35-55)-induced experimental autoimmune encephalomyelitis. | Q54030011 |
| | TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination. | Q54150165 |
| | Characterization of immune cell subsets during the active phase of multiple sclerosis reveals disease and c-Jun N-terminal kinase pathway biomarkers. | Q54648845 |
| | Defective T Cell Differentiation in the Absence of Jnk1 | Q58415329 |
| | Autophagy Is a Tolerance-Avoidance Mechanism that Modulates TCR-Mediated Signaling and Cell Metabolism to Prevent Induction of T Cell Anergy | Q58483027 |
| | Glutamate excitotoxicity in a model of multiple sclerosis | Q60450917 |
| | Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor-immunoglobulin fusion proteins | Q72194401 |
| | Relationships between T lymphocyte apoptosis and anergy following trauma | Q73376713 |
| | Astrocytes produce and release interleukin-1, interleukin-6, tumor necrosis factor alpha and interferon-gamma following traumatic and metabolic injury | Q73706122 |
| | Induction of experimental autoimmune encephalomyelitis in the absence of c-Jun N-terminal kinase 2 | Q74535805 |
| | Severity of symptoms and demyelination in MOG-induced EAE depends on TNFR1 | Q74578860 |
| | TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group | Q78130683 |
| | Signal transduction by the JNK group of MAP kinases | Q28142592 |
| | Interferon-γ: an overview of signals, mechanisms and functions | Q28207081 |
| | SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase | Q28364720 |
| | Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene | Q28507982 |
| | Integrated analysis of transcriptomic and proteomic data | Q28707991 |
| | The c-jun kinase/stress-activated pathway: regulation, function and role in human disease | Q30500831 |
| | Analysis of rodent growth data in toxicology studies | Q30679828 |
| | The stress-activated protein kinase pathways | Q33732869 |
| | A critical role of neural-specific JNK3 for ischemic apoptosis | Q34392478 |
| | Tumor necrosis factor-α signaling in macrophages. | Q34734335 |
| | Inactivation of JNK1 enhances innate IL-10 production and dampens autoimmune inflammation in the brain | Q35037296 |
| | T cell subsets and their signature cytokines in autoimmune and inflammatory diseases | Q35558638 |
| | Multiple sclerosis review. | Q35958691 |
| | IFN-γ ameliorates autoimmune encephalomyelitis by limiting myelin lipid peroxidation. | Q36056823 |
| | Regulation of c-Jun NH(2)-terminal kinase (Jnk) gene expression during T cell activation | Q36375882 |
| | c-Jun NH2-terminal kinase (JNK)1 and JNK2 have similar and stage-dependent roles in regulating T cell apoptosis and proliferation | Q36376229 |
| | c-Jun is a negative regulator of myelination. | Q36660683 |
| | JNK pathway: diseases and therapeutic potential | Q36794020 |
| | Reduction of microglial activity in a model of multiple sclerosis by dipyridamole. | Q37048242 |
| | Role of the JNK signal transduction pathway in inflammatory bowel disease | Q37054358 |
| | The interdependent, overlapping, and differential roles of type I and II IFNs in the pathogenesis of experimental autoimmune encephalomyelitis | Q37189412 |
| | Multiple sclerosis: experimental models and reality | Q37596784 |
| | Paeoniflorin Ameliorates Experimental Autoimmune Encephalomyelitis via Inhibition of Dendritic Cell Function and Th17 Cell Differentiation | Q37626083 |
| | The T lymphocyte in experimental allergic encephalomyelitis | Q37925549 |
| | Network Motifs in JNK Signaling. | Q38172167 |
| | The JNK are important for development and survival of macrophages | Q38316183 |
| | Reactive Astrocytes: Production, Function, and Therapeutic Potential | Q39388343 |
| | Rapid production of TNF-alpha following TCR engagement of naive CD8 T cells | Q40364726 |
| | A low molecular weight copper chelator crosses the blood-brain barrier and attenuates experimental autoimmune encephalomyelitis. | Q40555237 |
| | A novel gene iba1 in the major histocompatibility complex class III region encoding an EF hand protein expressed in a monocytic lineage | Q41183035 |
| | Diverse Roles of JNK and MKK Pathways in the Brain | Q41831736 |
| | Anergic T cells are defective in both jun NH2-terminal kinase and mitogen-activated protein kinase signaling pathways | Q42257560 |
| | The effect of the JNK inhibitor, JIP peptide, on human T lymphocyte proliferation and cytokine production | Q44402669 |
| | TRAIL-induced death of human adult oligodendrocytes is mediated by JNK pathway. | Q46736950 |
| | Differentiation of CD4+ T cells to Th1 cells requires MAP kinase JNK2. | Q48009840 |
| | Activation of mitogen-activated protein kinases in experimental autoimmune encephalomyelitis | Q48253143 |
| | TNF-induced death of adult human oligodendrocytes is mediated by c-jun NH2-terminal kinase-3. | Q48301208 |
| | Blocking glutamate carboxypeptidase II inhibits glutamate excitotoxicity and regulates immune responses in experimental autoimmune encephalomyelitis | Q48611622 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 10 | |
| P921 | main subject | experimental autoimmune encephalomyelitis | Q494066 |
| P577 | publication date | 2020-09-23 | |
| P1433 | published in | Cells | Q27724621 |
| P1476 | title | c-Jun N-Terminal Kinase as a Therapeutic Target in Experimental Autoimmune Encephalomyelitis | |
| P478 | volume | 9 | |